Does AI hype translate to profit?

From American public media, this is Marketplace Tech.

I'm Lily Dramale. It is Friday which means it's time for our week in review, Marketplace TechBites. On the show today, the FDA expands its approvals

for CRISPR gene editing therapies. We look at affordability of these treatments, which can cost

well into the millions of dollars.

Plus is bad marketing stunting health tech companies?

How startups can up their game.

But first at this week's World Economic Forum in Davos, Switzerland, there were 32

scheduled events devoted to, you guessed it, AI.

When they weren't comparing private jets, business executives were busy asking,

how do you make money off of AI? Our guest this week is Christina Farr,

a health tech investor at Omer's Ventures.

Just from my own seat as a health care investor,

every company seems to be an AI company these days.

Even if a year ago they were a services company

or doing something else entirely.

So it seems like we just want to sprinkle some AI pixie dust

and then say, you know, this is a big business opportunity

that's worth far more than it was previously. But I think you you're right we don't have a business model yet

And no one knows this is a space that a startup can even win maybe this is just something that the incumbents will

ultimately win.

I don't discount companies like Microsoft.

...